A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
Elevation Oncology
Stanford University
ADC Therapeutics S.A.
pharmaand GmbH
Genmab
Ludwig Institute for Cancer Research
Incyte Corporation
Gilead Sciences
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Western Regional Medical Center
Amgen
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc
Altor BioScience